Allegiance Financial Group Advisory Services LLC Invests $26,000 in Aethlon Medical, Inc. (NASDAQ:AEMD)

Allegiance Financial Group Advisory Services LLC acquired a new position in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 30,000 shares of the medical equipment provider’s stock, valued at approximately $26,000. Allegiance Financial Group Advisory Services LLC owned 0.21% of Aethlon Medical as of its most recent SEC filing.

Analysts Set New Price Targets

A number of research firms have recently weighed in on AEMD. StockNews.com upgraded shares of Aethlon Medical to a “sell” rating in a research report on Wednesday, February 19th. HC Wainwright restated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Wednesday, February 19th.

Aethlon Medical Price Performance

Shares of AEMD opened at $0.58 on Thursday. Aethlon Medical, Inc. has a one year low of $0.24 and a one year high of $1.85. The company has a market cap of $8.40 million, a P/E ratio of -0.37 and a beta of 1.88. The firm has a 50 day simple moving average of $0.67 and a two-hundred day simple moving average of $0.50.

Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings data on Wednesday, February 12th. The medical equipment provider reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.09. On average, analysts expect that Aethlon Medical, Inc. will post -0.73 earnings per share for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.